23 August 2019

Dutch social media regularly post about the safety of medicines for pregnant women. Many pregnant women use these posts as a source of information. A new analysis shows, however, that information found on social media about the risk of medication use often does not correspond with guidelines.
Researchers of the Radboud university medical center published their results in the British Journal of Clinical Pharmacology.

The study describes more than 1200 posts on social media platforms, ranging from online forums and blogs to Twitter and Facebook. 43% of these did not comply with the safety guidelines of the Teratology Information Service, the center of expertise for the effects of medication on pregnancy, the child and breastfeeding. Because many women do look online for information about the use of medication during their pregnancy, such erroneous information can influence their choices in a negative way.

How often information was correct or incorrect was not the same for all the posts. For medication with clear guidelines ("it's safe" or "it's not safe"), the posts were correct four out of five times. The more nuanced categories were more error-prone. For medicines lacking information to give advice to pregnant women, the posts were correct in 24% of the cases. For medication that is only prescribed on strict indication, only 7% was correct. These last two categories were often incorrectly described as either "safe" or "not safe."

The researchers point out two important implications of the research. First, more research needs to be conducted into the safety of medication use during pregnancy, so that medicines can be categorized less ambiguously. Secondly, the fact that much of the information that is shared on social media is incorrect argues in favor of the need for clear communication by healthcare providers about the use of medication during pregnancy. Lead researcher Marleen van Gelder: “This applies in particular to medication that is prescribed on strict indication, such as antidepressants. Because it is not just the person who puts the post on the internet who has an incorrect image of the safety; previous studies have also shown that this type of information can influence the decisions of pregnant women who read these posts.”

Marleen van Gelder is member of theme Healthcare improvement science.

Related news items


The PRIDE Study Evaluation of online methods of data collection

16 January 2020 In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study. read more

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019 With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success. read more

Ingenious solution, but what was the problem?

29 May 2019 In Value in Health Anouck Kluytmans, Marcia Tummers, Gert Jan van der Wilt and Janneke Grutters found, using a mixed methods approach, that although a recently developed medical technology was deemed ingenious by stakeholders, there was no underlying problem it could solve in its intended context. read more

Association of gestational weight gain with adverse maternal and infant outcomes

13 May 2019 An individual participant meta-analysis published in JAMA showed that pregnancy BMI is related stronger to maternal and infant complications than to gestational weight gain. The PRIDE Study, with coauthors Marleen van Gelder and Nel Roeleveld, was one of the participating cohorts. read more

Eddy Adang reappointed as member Health Council

21 November 2018 The Health Council of the Netherlands is an independent scientific advisory body whose legal task it is to advise ministers and Parliament in the field of public health and health/healthcare research. read more

TURBO grants for four medical-technical research projects

8 November 2018 Four TURBO grants were awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between Radboudumc and the University of Twente. read more